- Home
- CODA vs DTIL Comparison
CODA vs DTIL Comparison
Compare CODA & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CODA | DTIL |
|---|---|---|
| Founded | 1994 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.2M | 97.7M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | CODA | DTIL |
|---|---|---|
| Price | $10.52 | $4.25 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $60.00 |
| AVG Volume (30 Days) | 160.2K | ★ 251.1K |
| Earning Date | 03-16-2026 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 15.09 | N/A |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $24,347,217.00 | $698,000.00 |
| Revenue This Year | $30.82 | N/A |
| Revenue Next Year | $20.84 | $34.30 |
| P/E Ratio | $35.50 | ★ N/A |
| Revenue Growth | ★ 29.34 | N/A |
| 52 Week Low | $5.76 | $3.75 |
| 52 Week High | $12.22 | $8.82 |
Technical Indicators
Market Signals| Indicator | CODA | DTIL |
|---|---|---|
| Relative Strength Index (RSI) | 58.07 | 48.05 |
| Support Level | $10.75 | $3.90 |
| Resistance Level | $11.76 | $4.21 |
| Average True Range (ATR) | 0.74 | 0.29 |
| MACD | 0.03 | 0.06 |
| Stochastic Oscillator | 52.90 | 60.54 |
Price Performance
Historical ComparisonAbout CODA Coda Octopus Group Inc.
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.